Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- English’s Michael W. Clune examines the public response to work on economic inequality
- Psychology’s Jane Timmons-Mitchell discusses teen suicide prevention
- English’s Thrity Umrigar discusses her new novel
- New faculty-led lunchtime program starting Sept. 2
- Volunteer for RePlay for Kids toy repair workshop Sept. 2